Volume 9, Issue 3 (7-2011)                   IJRM 2011, 9(3): 187-192 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Khani B, Bahrami N, Mehrabian F, Naderi Naeni H. Icodextrin reduces adhesion formation following gynecological surgery in rabbits. IJRM 2011; 9 (3) :187-192
URL: http://ijrm.ir/article-1-235-en.html
1- Department of Obstetrics and Gynecology, Shahid Beheshti Hospital, Isfahan University of Medical Sciences, Isfahan, Iran , khani@med.mui.ac.ir
2- Department of Obstetrics and Gynecology, Alzahra Hospital, Isfahan University of Medical Sciences, Isfahan, Iran
3- Sepahan Hospital, Isfahan, Iran
Abstract:   (2423 Views)
Background: Adhesion is a common complication of gynecology surgery so different barrier agents and solutions have been used during these operations to separate and protect tissues from adhesion after surgery. Adept is one of these solutions that have been postulated to reduce the chance of adhesion following gynecolgy surgery.
Objective: To evaluate the effect of 4% icodextrin in reducing adhesion formation in comparing with sterile water and human amniotic fluid in rabbits. Materials and Methods: In this prospective experimental study 30 white Newzealand female rabbits were selected and randomized in to three treatment groups. The rabbits were anesthetized and an abdominal incison was made, uterine horns were abrated with gauze until bleeding occurred. Before closing the abdomen, the traumatized area was irrigated either by 30cc of sterile water, 30cc of 4% Adept or 30cc of human amniotic fluid. The solutions were labeled only as solutions A (steriel water), B (icodextrin), or C (human amniotic fluid). On the seventh day after surgery, second laparotomy was performed to determine and compare adhesion formation in rabbits.
Results: There was significant difference between mean score of adhesions in 4% icodextrin group (2.1±0.70) in comparison to sterile water group (10.4±0.60) and amniotic fluid group (8.7±0.84). But the difference between mean score of adhesions in amniotic fluid group in comparison to sterile water group was not significant (8.7±0.84) versus (10.4±0.60).
Conclusion: The use of 4% icodextrin solution was more effective than human amniotic fluid and sterile water in reducing adhesion formation in a gynecological surgery model in rabbits
Full-Text [PDF 204 kb]   (755 Downloads) |   |   Full-Text (HTML)  (364 Views)  
Type of Study: Original Article |

References
1. Liakakos T, Thomakos N, Fine PM, Dervenis C, Young RL. Peritoneal adhesions: etiology, pathophysiology, and clinical significance. Recent advances in prevention and management. Dig Surg 2001; 18: 260-273. [DOI:10.1159/000050149]
2. Muller SA, Treutner KH, Haase G, Kinzel S, Tietze L, Schumpelick V. Effect of intera peritonealanti adhesive fluids in a rat peritonitis model. Archsurg 2003; 138: 286-290. [DOI:10.1001/archsurg.138.3.286]
3. Farquhar C, Vandekerckhove P, Watson A, Vail A, Wiseman D. Barrier agents forpreventing adhesions after surgery for subfertility. Cochrane Database Syst Rev 2000; 2: CD000475.
4. Sekiba K. Use of Interceed (TC7) absorbable adhesion barrier to reduce postoperative adhesion reformation in infertility and endometriosis surgery. The Obstetrics and Gynecology Adhesion Prevention Committee. Obstet Gynecol 1992; 79: 518-522.
5. Burd DA, Greco RM, Regauer S, Longaker MT, Siebert JW, Garg HG. Hyaluronan and wound healing: a newperspective. Br J PlastSurg 1991; 44: 579-584. [DOI:10.1016/0007-1226(91)90093-Y]
6. Hosie K, Gilbert JA, Kerr D, Brown CB, Peers EM. Fluid dynamics in man of an intra peritoneal drug delivery solution: 4% icodextrin. Drug Deliv 2001; 8: 9-12. [DOI:10.1080/107175401300002694]
7. Dizerega GS, Verco SJ, Young P, Kettel M, Kobak W, Martin D, et al. A randomized, controlled pilot study of the safety and efficacy of 4% icodextrin solution in the reduction of adhesions following laparoscopic gynaecological surgery. Hum Reprod 2002; 17:1031-1038. [DOI:10.1093/humrep/17.4.1031]
8. Roman H, Canis M, Kamble M, Botchorishvili R, Pouly JL, Mage G. Efficacy of three adhesion preventive agent in reducing severe peritoneal truma induced in a laparoscopic rat model. Fertil Steril 2005; 83: 1113-1118. [DOI:10.1016/j.fertnstert.2004.08.039]
9. Muller SA, Treutner KH, Jorn H, Anurov M, Ottinger AP, Schumpelick V. Adhesion prevention comparing liquid and solid barriers in the rabbit uterine horn model. Eur J Obstet Gynecol Reprod Biol 2005; 120: 222-226. [DOI:10.1016/j.ejogrb.2004.09.011]
10. Metwally M, Watson A, Lilford R, Vandekerckhove P. Fluid and pharmacological agents for adhesion prevention after gynaecological surgery. Cochrane Database Syst Rev 2006; 19: CD001298. [DOI:10.1002/14651858.CD001298.pub3]
11. Saedon M, Borowski DW, Natu S, Hennessy C, Tabaqchali MA. David W Borowski, SonaliNatu, Colm Hennessy. Adept (Icodextrin 4%): A tale of caution. Colorectal Dis 2010; 12: 384-386. [DOI:10.1111/j.1463-1318.2009.02007.x]
12. Reichel W, Schulze B, Dietze J, Mende W. A case of sterile peritonitis associated with icodextrin solution. Perit Dial Int 2001; 21: 414-419.
13. Kamffer WJ, Jooste EV, Nel JT, de Wet JI. Surgical glove powder and intraperitoneal adhesion formation. An appeal for the use of powder-free surgical gloves. S Afr Med J 1992; 81: 158-159.
14. Wilson MS, Menzies D, Knight AD, Crowe AM. Demonstrating the clinical and cost effectiveness of adhesion reduction strategies. Colorectal Dis 2002; 4: 355-360. [DOI:10.1046/j.1463-1318.2002.00374.x]
15. Lower AM, Hawthorn RJS, Ellis H, O'Brien F, Buchan S, Crowe AM. The impact of adhesions on hospital readmissions over ten years after 8849 open gynaecological operations: anassessment from the SurgicalandClinical Adhesions Research Study. Br J Obstet Gynaecol 2000; 107: 855-862. [DOI:10.1111/j.1471-0528.2000.tb11083.x]
16. Lower AM, Hawthorn RJS, Clark D, Boyd JH, Finlayson AR, Knight AD, et al. Adhesionrelated readmissions following gynaecological laparoscopy or laparotomy in Scotland: an epidemiological study of 24,046 patients. Hum Reprod 2004; 19: 1877-1885. [DOI:10.1093/humrep/deh321]
17. Rimbach S, Korell M, Tinneberg HR, DeWilde RL. Adhesions and their prevention in gynaecologic surgery: current status and consensus based on four workshops. Geburtsh Frauenheilk 2004; 64: 891-899. [DOI:10.1055/s-2004-821239]
18. Lancey JT. The prevention of peritoneal adhesions by amniotic fluid. Ann Surg 1930; 92: 281-293. [DOI:10.1097/00000658-193008000-00014]
19. Longaker MT, Chiu ES, Harrison MR, Crombleholme TM, Langer JC, et al. Studies in fetal wound healing. IV. Hyaluronic acid-stimulating activity distinguishes fetal wound fluid from adult wound fluid. Ann Surg 1989; 667-672. [DOI:10.1097/00000658-198911000-00016]
20. Johns DB, Keyport GM, Hoehler F, diZerega GS; Intergel Adhesion Prevention Study Group. Reduction of postsurgical adhesions with Intergel adhesion prevention solution: a multicenter study of safety and efficacy after conservative gynecologic surgery. Fertil Steril 2001; 76: 595-604. [DOI:10.1016/S0015-0282(01)01954-9]
21. Lundorff P, Geldorp H, Tronstad SE, Lalos O, Larsson B, Johns DB, et al. Reduction of postsurgical adhesions with ferric hyaluronate gel: a European study. Hum Reprod 2001; 16: 1982-1988. [DOI:10.1093/humrep/16.9.1982]
22. Pellicano M, Bramante S, Cirillo D, Palomba S, Bifulco G, Zullo F, et al. Effectiveness of autocrosslinked hyaluronic acid gel after laparoscopic myomectomy in infertile patients: a prospective, randomized, controlled study. Fertil Steril 2003; 80: 441-444. [DOI:10.1016/S0015-0282(03)00597-1]
23. Rodgers KE, Verco SJS, diZerega GS. Effects of intraperitoneal 4% icodextrin solution onthe healing of bowel anastomoses and laparotomy incisions in rabbits. Colorectal Dis 2003; 5: 324-330. [DOI:10.1046/j.1463-1318.2003.00447.x]
24. Flessner MF, Lofthouse J. Of mice and men: species and age difference in dialysis withicodextrin. J Am Soc Nephrol 1999; 10: 226A.
25. Verco SJS, Peers EM, Brown CB, Rodgers KE, Roda N, diZerega G. Development of a novel glucose polymer solution (icodextrin) for adhesionprevention: pre-clinicalstudies. Hum Reprod 2000; 15: 1764-1772. [DOI:10.1093/humrep/15.8.1764]
26. Rodgers KE, Verco SJ, diZerega GS. Effects of intraperitoneal 4% icodextrin solution on the healing of bowel anastomoses and laparotomy incisions in rabbit. Colorectal Dis 2003; 5: 324-330. [DOI:10.1046/j.1463-1318.2003.00447.x]
27. Santos LM, Frenna V, Thoma V, Wattiez A. Disseminated intravascular coagulation after laparoscopic multiple myomectomy with use of icodextrin. J Minim Invasive Gynecol 2006: 13, 480-482. [DOI:10.1016/j.jmig.2006.05.013]
28. Doumplis D, Majeed GS, Sieunarine k, Richardson R, Smith JR. Adverse effects related to icodextrin 4% our experience.Gynecol Surg 2007; 4: 97-100. [DOI:10.1007/s10397-006-0267-0]
29. Catena F, Ansaloni L, Lauro A, Ercolani G, D'Alessandro L, Pinna A. Prospective controlled randomized trial on prevention of postoperative abdominal adhesions by Icodextrin 4% solution after laparotomic operation for small bowel obstruction caused by adherences. Trials 2008; 9: 74. [DOI:10.1186/1745-6215-9-74]
30. Brown CB, Luciano AA, Martin D, Peers E, Scrimgeour A, diZerega GS, et al. Adept (icodextrin 4% solution) reduces adhesions after laparoscopic surgery for adhesiolysis: a double-blind, randomized, controlled study. Fertil Steril 2007; 88: 1413-1426. [DOI:10.1016/j.fertnstert.2006.12.084]

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb